pharmaphorum

DECEMBER 18, 2022

The clerical overhead of enrolment forms navigated over fax and phone calls fails to deliver on the promise, resulting in lower-than-expected prescription volumes and lacklustre adoption among prescribers. The post Access solutions: the missing link that prevents biopharma innovation from reaching patients appeared first on.

Biopharma 81

Biopharma Patients Prescription Medical 81

MedCity News

AUGUST 9, 2024

The White House might soon finalize a rule that will either save or cost patients billions of dollars in prescription drug costs. The rule concerns “copay accumulators,” which are programs health plans use to prevent copay assistance from counting toward patients’ deductibles or out-of-pocket maximums.

Prescription 128

Prescription Patients Biopharma 128

MedCity News

JANUARY 23, 2023

As pharma becomes part of the value-based revolution, there are several lessons that can be learned from the ongoing development of value-based care.

Prescription 92

Prescription Pharma Biopharma 92

Pharmaceutical Commerce

DECEMBER 6, 2023

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

Biopharma 64

Biopharma Prescription Patients 64

MedCity News

JULY 21, 2023

What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.

Prescription 96

Prescription Patients Biopharma Medical 96

MedCity News

JULY 30, 2023

The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.

FDA 87

FDA Prescription Pharma Biopharma 87

MedCity News

JULY 28, 2022

Prescription digital therapeutics can and should be considered as part of type 2 diabetes therapies. While pharmaceuticals are a critical piece of the treatment landscape for type 2 diabetes, they have been the exclusive and de-facto first-line treatment for too long.

Pharmaceutical 118

Pharmaceutical Prescription Biopharma 118

MedCity News

APRIL 2, 2023

Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.

FDA 114

FDA Prescription Biopharma Pharma 114

MedCity News

DECEMBER 8, 2023

Prescriptions for GLP-1s are soaring, but fewer than a third of people prescribed the costly drugs will continue taking them one year later without personalized support.

Prescription 117

Prescription Biopharma 117

MedCity News

APRIL 10, 2023

Pear Therapeutics’ Chapter 11 bankruptcy filing follows three corporate restructurings and the inability to secure additional financing to support commercialization of its FDA-cleared prescription digital therapeutics. An auction of Pear’s assets is expected to happen in early May.

Prescription 106

Prescription FDA Biopharma 106

pharmaphorum

JULY 18, 2022

The separation leaves GSK as a biopharma and vaccines pure-play that chief executive Emma Walmsley has said will deliver £33 billion in annual revenues by 20231, up from £24.5 Last year, GSK rejected a $68 billion bid from Unilever for the consumer health operations, saying the offer “fundamentally undervalued” the business.

Biopharma 96

Biopharma Sales Prescription Pharma 96

MedCity News

OCTOBER 24, 2022

Specialty carve outs that move specialty drugs away from traditional prescription drug management to a pharmacy benefit administrator (PBA) or specialty administrator will continue and likely to provide cost savings.

Prescription 98

Prescription Pharmaceutical Patients Management 98

Zymewire

SEPTEMBER 15, 2023

The bill also enables Medicare to negotiate prescription drug prices and extends the Affordable Care Act through 2025. Signed into law in August 2022, the Inflation Reduction Act (IRA) was designed to fight inflation, invest in domestic (US) energy production & manufacturing, and reduce carbon emissions.

Biopharma 52

Biopharma Prescription Manufacturing 52

MedCity News

MARCH 13, 2023

Price transparency has come a long way over the past couple of years, with insurance companies and hospitals now required to publicly disclose their prices. The more pressing issue is that there is no mechanism in place to make this information easily digestible, personalized to each patient, and placed in context with competitors’ prices.

Doctors 75

Doctors Prescription Insurance Patients 75

MedCity News

MARCH 19, 2023

Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.

Prescription 95

Prescription Prospecting FDA Biopharma 95

PM360

MAY 23, 2024

Bryan Johnson Senior Director, Product Management, Compass Prescriber Veeva Systems Paving the Way to Faster Treatment Starts Bryan’s exposure to life sciences started at a young age, watching his father’s career at companies like Johnson & Johnson and emerging biopharmas. As rare diseases affect about 1 in 10 people in the U.S.,

Retail 52

Retail Biopharma Prescription Healthcare Provider 52

MedCity News

FEBRUARY 4, 2024

In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. By enforcing transparency, PBMs would need to release detailed information on prescription drug spending. 2024 stands at a critical juncture in the battle against soaring pharmacy costs. Transparency and reporting requirements.

Prescription 101

Prescription Networking Management Pharmaceutical 101

MedCity News

JULY 13, 2023

FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.

FDA 86

FDA Prescription Healthcare Healthcare 86

MedCity News

DECEMBER 27, 2022

Earlier this year, CMS implemented a new Level II Healthcare Common Procedure Coding System (HCPCS) code for “prescription digital behavioral therapy,” which makes it easier for commercial and Medicaid plans to cover these therapies. Additionally.

Healthcare 79

Healthcare Healthcare Prescription Biopharma 79

pharmaphorum

JUNE 12, 2017

Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans.

Marketing 52

Marketing Engineering Biopharma Prescription 52

MedCity News

JULY 11, 2023

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

FDA 68

FDA Prescription Biopharma Medical 68

MedCity News

AUGUST 27, 2023

doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events. The Walt Disney Company excels in designing exceptional service because they are hyper-focused on listening, tracking, designing, and measuring the experiences of guests visiting their properties.

Healthcare 75

Healthcare Healthcare Prescription Doctors 75

MedCity News

JUNE 12, 2023

Bringing the very first prescription digital therapeutic (PDT) to market in 2017, Pear Therapeutics went above and beyond to follow suggested regulatory guidelines, obtained Food & Drug Administration (FDA) clearance, and provided solid clinical study evidence. Photo: Bulat Silvia, Getty Images

Food and Drug Administration 90

Food and Drug Administration Prescription Government FDA 90

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

pharmaphorum

DECEMBER 23, 2022

With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.

Marketing 87

Marketing Sales Medical Patients 87

Pharmaceutical Technology

JANUARY 4, 2023

Ondansetron hydrochloride CR is under clinical development by RedHill Biopharma and currently in the Phase II and Phase III in clinical pathway. RedHill Biopharma overview RedHill Biopharma (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer.

Biopharma 40

Biopharma Prescription Pharmaceutical 40

pharmaphorum

OCTOBER 24, 2022

Sumitomo and its subsidiary Sumitovant Biopharma initially offered $22.75 At the time, Myovant said Myfembree was the market leader in the oral GnRH category with a 51% share in new prescriptions for uterine fibroids that was keeping it ahead of main rival AbbVie/Neurocrine Biosciences’ Orilissa/Oriahnn (elagolix).

Biopharma 59

Biopharma Marketing Pharma Prescription 59

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. Total revenues came in at £6.9 billion ($8.3 GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion.

Sales 52

Sales Biopharma Prescription Medicine 52

Pharmaceutical Technology

NOVEMBER 4, 2022

For example, digital twins of pharmaceutical supply chains can predict bottlenecks and give suggestions for how to respond using prescriptive AI. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

pharmaphorum

SEPTEMBER 26, 2022

Mackay has been CFO at the UK big pharma since the beginning of 2019, and is departing the company shortly after the spin-out of consumer health business Haleon in order to focus on prescription drugs and vaccines. billion and $1.9 billion, respectively.

Management 52

Management Pharma Biopharma Prescription 52

Clarivate

FEBRUARY 28, 2023

Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021.

Prescription 98

Prescription Patients Pharmacology Healthcare 98

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The speciality drug channel participants, including speciality pharmacies, biopharma companies, and distributors, are transforming their operations with automated and secure data systems and next-generation analytics, which will improve data collection, partner performance and strategy effectiveness. . Prescription refill and renewal.

Specialization 45

Specialization Leads Pharma Side effects 45

pharmaphorum

JUNE 24, 2022

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness. ” The post Biogen and Happify partner on digital support for MS patients appeared first on.

Patients 40

Patients Prescription Biopharma Insurance 40

Clarivate

DECEMBER 14, 2021

Patients are most active searching for online health information when preparing for a doctor visit, when 19% do so; after a doctor’s appointment (20%); and after receiving a prescription but before getting it filled (19%).More 2021 study had researched prescription drug topics online in the past year.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices.

FDA 52

FDA Prescription Medicine Biopharma 52

PM360

JULY 21, 2022

The medication referenced in this case study is a prescription medication used, along with diet and exercise, to lower blood sugar in adults with type 2 diabetes. Veradigm provides biopharma marketers an opportunity to deliver awareness messages directly to the HCPs of interest, during their point of care workflow.

Physicians 52

Physicians Media Pharma sales reps Electronics 52